Updates on Clostridium difficile in Europe Advances in Microbiology, Infectious Diseases and Public Health Volume 8 /

This book outlines the currently available clinical, epidemiological and experimental data on Clostridium difficile infection (CDI) with special emphasis on studies and results achieved in Europe. The incidence and severity of CDI has increased significantly over the last decade, and the book explai...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Mastrantonio, Paola (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt), Rupnik, Maja (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Cham : Springer International Publishing : Imprint: Springer, 2018.
Έκδοση:1st ed. 2018.
Σειρά:Advances in Microbiology, Infectious Diseases and Public Health, 1050
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 05450nam a2200517 4500
001 978-3-319-72799-8
003 DE-He213
005 20191025141037.0
007 cr nn 008mamaa
008 180130s2018 gw | s |||| 0|eng d
020 |a 9783319727998  |9 978-3-319-72799-8 
024 7 |a 10.1007/978-3-319-72799-8  |2 doi 
040 |d GrThAP 
050 4 |a QR46 
072 7 |a MMFM  |2 bicssc 
072 7 |a MED052000  |2 bisacsh 
072 7 |a MKFM  |2 thema 
082 0 4 |a 616.9041  |2 23 
245 1 0 |a Updates on Clostridium difficile in Europe  |h [electronic resource] :  |b Advances in Microbiology, Infectious Diseases and Public Health Volume 8 /  |c edited by Paola Mastrantonio, Maja Rupnik. 
250 |a 1st ed. 2018. 
264 1 |a Cham :  |b Springer International Publishing :  |b Imprint: Springer,  |c 2018. 
300 |a VIII, 261 p. 25 illus., 16 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Advances in Microbiology, Infectious Diseases and Public Health,  |x 2365-2675 ;  |v 1050 
505 0 |a Foreword (P. Mastrantonio and M. Rupnik) -- Economic burden of CDI in European countries (E. Reigadas and E. Bouza) -- The need for European surveillance of CDI(C. Wiuff, A.Lan Banks, F. Fitzpatrick, L. Cottom) -- Diagnostic guidance for C. difficile infections (M.J.T. Crobach,A.Baktash, N. Duszenko, E.J. Kuijper) -- Ribotypes and new virulent strains across Europe (J. Couturier, K. Davies, C. Gateau, F. Barbut) -- Comparative genomics of C. difficile strains (S. Janezic, J.R.Garneau, M. Monot) -- Cellular uptake and mode-of-action of Clostridium difficile toxins (P.Papatheodorou, H. Barth, N. Minton, K. Aktories) -- Clostridium difficile biofilm (C. Vuotto, G. Donelli, A. Buckley, C. Chilton) -- European practice for CDI treatment (F. Fitzpatrick, M. Skally, M. Brady, K. Burns, C. Rooney, M.H. Wilcox) -- Antibiotic resistances of Clostridium difficile (P. Spigaglia, P. Mastrantonio, F. Barbanti) -- Probiotics for prevention and treatment of Clostridium difficile infection (L. Valdés-Varela, M. Gueimonde, P. Ruas-Madiedo) -- Faecal microbiota transplantation as emerging treatment in European countries (M. Maida, J. McIlroy, G. Ianiro, G. Cammarota) -- Immunization strategies against Clostridium difficile (J.F. Bruxelle, S. Péchiné, A. Collignon) -- Non-human C. difficile reservoirs and sources: animals, food, environment (C. Rodriguez Diaz, C. Seyboldt , M. Rupnik) -- The ESCMIDStudy Group for Clostridium difficile: history, role and perspectives (J.E. Coia and E.J. Kuijper). 
520 |a This book outlines the currently available clinical, epidemiological and experimental data on Clostridium difficile infection (CDI) with special emphasis on studies and results achieved in Europe. The incidence and severity of CDI has increased significantly over the last decade, and the book explains why C. difficile, recently reclassified as Clostridioides difficile, remains a significant challenge, also from economic perspective, to health care systems all over the world. The different reservoirs of this ubiquitous microorganism are reviewed as well as the different factors contributing to its virulence, such as toxins and biofilm formation. The rapid evolution of antibiotic resistance is clearly a concern and in a specific way can influence the CDI epidemiology. Additionally, new emerging strains and comparative genomics studies are discussed for their relevance from epidemiological and evolutionary point of view. The book also gives an overview on diagnostics, therapy and surveillance, all of which are still challenging. Therefore, a closer look is taken on the effect of probiotics as an alternative to antibiotics, for prevention and treatment of CDI. Fecal transplantation from healthy donors, passive immunotherapies and vaccines for patients with recurrences are also discussed in dedicated chapters. The book closes with a summary of the history and the achievements of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Clostridium difficile (ESGCD) written by the current and past presidents of the Society. It is the aim of this book to raise awareness on CDI and to disseminate updated information on its prevention, diagnosis and treatment. 
650 0 |a Medical microbiology. 
650 0 |a Infectious diseases. 
650 0 |a Microbiology. 
650 1 4 |a Medical Microbiology.  |0 http://scigraph.springernature.com/things/product-market-codes/B16003 
650 2 4 |a Infectious Diseases.  |0 http://scigraph.springernature.com/things/product-market-codes/H33096 
650 2 4 |a Microbiology.  |0 http://scigraph.springernature.com/things/product-market-codes/L23004 
700 1 |a Mastrantonio, Paola.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Rupnik, Maja.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9783319727981 
776 0 8 |i Printed edition:  |z 9783319728001 
776 0 8 |i Printed edition:  |z 9783319892108 
830 0 |a Advances in Microbiology, Infectious Diseases and Public Health,  |x 2365-2675 ;  |v 1050 
856 4 0 |u https://doi.org/10.1007/978-3-319-72799-8  |z Full Text via HEAL-Link 
912 |a ZDB-2-SBL 
950 |a Biomedical and Life Sciences (Springer-11642)